Login / Signup

Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study.

Daniel Chun-Suk OhPaul HaffeyAnkur PatelAmitabh Gulati
Published in: Pain medicine (Malden, Mass.) (2021)
Intravenous ketamine may be a safe and effective adjuvant treatment for CNP, especially with serotonin-norepinephrine reuptake inhibitors. Larger, prospective studies are warranted and should explore parameters to help prognosticate response to ketamine infusions.
Keyphrases
  • pain management
  • chronic pain
  • high dose
  • early stage
  • combination therapy
  • childhood cancer